Cervical cancer is an important area of action for any cancer control programme because of the burden of disease, and the potential for effective prevention through screening. Cervical cancer hardly presents any symptoms in its early stages and it highlights the importance of regular screening for the disease. Screening is looking for cancer before a person has any symptoms. This can help to find the cancer at an early stage. When abnormal tissue or cancer is found early, it may be easier to treat.
Screening programs involve the testing of asymptomatic individuals with a precise screening test to identify those who likely to have the disease of interest and for the further investigation to confirm or exclude the disease. The aim of cancer screening is to prevent the cancer deaths and to improve the quality of life by finding cancers in early stage and by effectively treating them.
A choice to familiarize a screening program in public health services depends on the evidence that the benefits overshadow the harms of screening, disease burden, availability of suitable screening test, effective treatment, adequate resources, and efficient health services. Screening programs should achieve high participation for testing, diagnosis, and treatment. The population based cervical cancer screening programs have not yet been executed in many of the developing countries, despite the fact that cervical cancer has the greatest burden in developing countries, which is largely related to poverty, lack of resources and infrastructure and disqualification of women.
India accounts for 25% of global cervical incidences and death in annually in India. At present Women population accounts for approximately 49% of total Indian population. Among the total female population base, urban woman appears to be much aware of cervical screening test as compared to rural counterparts. Currently, there are VIA and Pap Smear test most common for cervical screening, but have their own disadvantages like inconvenience and less predictive and more confirmatory and surgical in nature.
Cervical cancer screening market in India is in still infancy stage. Currently the market is highly unorganized in the nature as most of the screening tests are performed in hospitals or under public programmes. The demand for cervical cancer screening is expected to rise with increasing awareness and growing concerns regarding second most common type of cancer causing large number of deaths among women in the country. The current degree of competition in terms of cervical screening in Indian is minimal with the availability of 2-3 players in the market.
There exist ample unexplored opportunity for various stake holders of the cervical screening market in India. Currently there is no big player in the market having national or regional level reach in Indian market. The entry restraints are minimal except the initial level of investment required to setup the operations. The large female population base serve as the untapped market potential along with the expansion growth opportunities in the future.
“India Cervical Cancer Screening Market Outlook 2022” research report discusses all aspects related to the cervical cancer screening market in India. Report gives comprehensive insight on the current accessible cervical screening approaches available in India. The various market dynamics discussed in the report offers unexplored opportunity for all stakeholders involved in the industry to expand their operations in Indian cervical screening market.
